STOCK TITAN

IGM Biosciences to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

IGM Biosciences, a clinical-stage biotechnology firm, announced that CEO Fred Schwarzer will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on June 2, 2021, at 1:00 p.m. EDT. A live webcast can be accessed via the company's 'Events and Presentations' page on its website, with a replay available for 90 days post-event. IGM focuses on developing engineered IgM antibodies for various diseases, aiming to overcome manufacturing challenges since 2010.

Positive
  • None.
Negative
  • None.

MOUNTAIN VIEW, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on June 2, 2021 at 1:00 p.m. EDT.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of multiple diseases. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact

Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com


FAQ

What is the date and time of the IGM Biosciences fireside chat?

The IGM Biosciences fireside chat is scheduled for June 2, 2021, at 1:00 p.m. EDT.

Where can I watch the IGM Biosciences conference webcast?

The live webcast of the IGM Biosciences conference can be watched on the 'Events and Presentations' page of their website.

How long will the IGM Biosciences webcast be available?

The replay of the IGM Biosciences webcast will be archived for 90 days following the presentation.

What is the main focus of IGM Biosciences?

IGM Biosciences focuses on creating and developing engineered IgM antibodies for the treatment of multiple diseases.

Who is the CEO of IGM Biosciences?

The CEO of IGM Biosciences is Fred Schwarzer.

IGM Biosciences, Inc.

NASDAQ:IGMS

IGMS Rankings

IGMS Latest News

IGMS Stock Data

416.25M
21.74M
35.05%
63.99%
4.78%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MOUNTAIN VIEW